Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry

Previous work demonstrated that serum metabolomics can distinguish pancreatic cancer from benign disease. However, in the clinic, non-pancreatic periampullary cancers are difficult to distinguish from pancreatic cancer. Therefore, to test the clinical utility of this technology, we determined whethe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Metabolites
Main Authors: McConnell, Yarrow J., Farshidfar, Farshad, Weljie, Aalim M., Kopciuk, Karen A., Dixon, Elijah, Ball, Chad G., Sutherland, Francis R., Vogel, Hans J., Bathe, Oliver F.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372206/
https://ncbi.nlm.nih.gov/pubmed/28098776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7010003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares